[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_510 

# __Reduction in airborne virus concentration__

## Articles mentionning this Benefit

* [Ventilation use in nonmedical settings during COVID-19: Cleaning protocol, maintenance, and recommendations](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_104.md)

## Category to which it belongs

* [Enhanced measures to inhibit the dissemination and transmission of viruses, including reducing concentration and spread.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_10.md)

## Description of actual returns pertaining to this benefit

* [Private investors investing in uvgi devices can benefit from improved occupant health and safety, enhanced reputation for prioritizing public health, and reduced absenteeism and healthcare costs.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_558.md)

## Name of the Benefit

Ultraviolet germicidal irradiation (UVGI) devices can disinfect air and surfaces, reducing the concentration of airborne viruses and the risk of transmission

## Risks which can benefit from this action

* [Use of uvgi devices](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_521.md)

## Stakeholders benefitting from this Benefit

* [Building occupants](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_97.md)

